Root Financial Partners’s Xenon Pharmaceuticals XENE Stock Holding History

Root Financial Partners’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40	Closed	-$2.33K	–	3217
2026 Q1	$2.33K	Buy	+40	New	+$1.84K	﹤0.01%	2254

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Root Financial Partners's XENE Position: Q2 2026 in Review

Root Financial Partners sold out of Xenon Pharmaceuticals (XENE) in Q2 2026, closing a stake of 40 shares — an estimated $2.33K sold.

Root Financial Partners first reported a position in XENE in Q1 2026 and held it in 1 quarter. The position peaked at $2.33K in Q1 2026. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

Root Financial Partners reported no remaining Xenon Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Root Financial Partners sold 40 Xenon Pharmaceuticals shares in Q2 2026, an estimated $2.33K.
Root Financial Partners first reported a position in Xenon Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Root Financial Partners's Xenon Pharmaceuticals position peaked at $2.33K in Q1 2026.
315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.